Zai Lab Ltd (NASDAQ:ZLAB)
| 44.90 Delayed Data As of Jan 27 |  +0.43 / +0.97%Today’s Change | 20.98 Today|||52-Week Range 61.29 | +46.25% Year-to-Date |
Latest ZLAB News | Press Releases
| Zai Lab Limited Unsponsored ADR (ZLAB) Soars 17.6%: Is Further Upside Left in the Stock? Jan 16 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 44.47 |
| Today’s open | 44.59 |
| Day’s range | 43.70 - 45.00 |
| Volume | 24,629 |
| Average volume (3 months) | 686,697 |
| Market cap | $4.4B |
Data as of 3:59pm ET, 01/27/2023
Growth & Valuation
| Earnings growth (last year) | -118.80% |
| Earnings growth (this year) | +34.83% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +194.77% |
| P/E ratio | NM |
| Price/Sales | 40.50 |
| Price/Book | 31.08 |
Competitors
Data as of 4:00pm ET, 01/27/2023
Financials
| Next reporting date | May 3, 2023 |
| EPS forecast (this quarter) | -$1.11 |
| Annual revenue (last year) | $144.3M |
| Annual profit (last year) | -$704.5M |
| Net profit margin | -488.16% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Shanghai, Shanghai |
Forecasts
